Abstract:We have tailored multifaceted chemistries into the manufacture of artificial virus-like delivery vehicles mimicking viral "intelligent" transportation pathways through sequential biological barriers; these vehicles can acquire the ability to dynamically "program transfer" to their target sites. To accomplish this, we created anionic pro-proteins, which facilitate charge reversal when subject to acidic endosomal pH; in this way, carboxylation reactions are performed on proteins with amine-reactive cis-aconitic anhydride. Electrostatic associations then initiate the envelopment of these pro-proteins into multilayered nanoarchitectural vehicles composed of multiple-segmental block copolycationic cyclic Arg-Gly-Asp (RGD)-poly(ethylene glycol)(PEG)-GPLGVRG-polylysine(thiol). Therefore, upon the pro-proteins' initial binding to the tumors via the protruding RGD ligands, the bio-inert PEG surroundings are detached through the enzymolysis of the intermediate GPLGVRG linkage by tumor-enriched matrix metalloproteinases, unveiling the cationic polylysine palisade and imparting intimate affinities to the anionic cytomembranes of the targeted tumors. Essentially, through their active endocytosis into the subcellular endosomal compartments, the pro-proteins are made capable of retrieving the original amine groups through a charge reversal decarboxylation process, consequently eliciting augmented charge densities (charge nonstoichiometric protein@polylysine(disulfide)) to disrupt the anionic endosomal membranes to facilitate translocation into the cytosol. Eventually, the active protein payloads can be liberated from nonstoichiometric protein@polylysine(thiol) by the disassembly of polylysine palisade upon the cleavage of disulfide crosslinking in response to the very high level of glutathione in the cytosol, thereby contributing toward extreme cytotoxic potency. Hence, our elaborated virus-mimicking platform has demonstrated potent antitumor efficacy through the systemic administration of ribonucleases, which will consequently lead to an innovative new therapeutic method by which proteins could reach intracellular targets.

Dynamic-responsive Virus-Mimetic Nanocapsules Facilitate Protein Drug Penetration and Extracellular-Specific Unpacking for Antitumor Treatment

Protein Nanoparticles Directed Cancer Imaging and Therapy

Protein-Based Artificial Nanosystems in Cancer Therapy

A Virus-Mimicking Ph-Responsive Acetalated Dextran-Based Membrane-Active Polymeric Nanoparticle For Intracellular Delivery Of Antitumor Therapeutics

Nanodelivery of a Self-Assembling Prodrug with Exceptionally High Drug Loading Potentiates Chemotherapy Efficacy.

Self-Assembly of Extracellular Vesicle-like Metal-Organic Framework Nanoparticles for Protection and Intracellular Delivery of Biofunctional Proteins.

"Spear and Shield in One" Nanochaperone Enables Protein to Navigate Multiple Biological Barriers for Enhanced Tumor Synergistic Therapy.

Protein Nanotherapeutics as an Emerging Modality for Cancer Therapy

Degradable polymeric nanocapsule for efficient intracellular delivery of a high molecular weight tumor-selective protein complex

Capsid-Like Supramolecular Dendritic Systems As Ph-Responsive Nanocarriers for Drug Penetration and Site-Specific Delivery

A Novel Intracellular Protein Delivery Platform Based on Single-Protein Nanocapsules

Nanocarriers for intracellular delivery of proteins in biomedical applications: strategies and recent advances

Drug-delivering-drug platform-mediated potent protein therapeutics via a non-endo-lysosomal route.

Antitumor Therapeutics: A Virus‐Mimicking Ph‐responsive Acetalated Dextran‐Based Membrane‐Active Polymeric Nanoparticle for Intracellular Delivery of Antitumor Therapeutics (adv. Funct. Mater. 51/2019)

Charge-Reversible Pro-Ribonuclease Enveloped in Virus-like Synthetic Nanocapsules for Systemic Treatment of Intractable Glioma

Virus-mimicking Mesoporous Organosilica Nanocapsules with Soft Framework and Rough Surface for Enhanced Cellular Uptake and Tumor Penetration

Robust and smart polypeptide-based nanomedicines for targeted tumor therapy

Protein@Inorganic Nanodumpling System for High-Loading Protein Delivery with Activatable Fluorescence and Magnetic Resonance Bimodal Imaging Capabilities

The Potential of Biomimetic Nanoparticles for Tumor-Targeted Drug Delivery

Multiple targeting strategies achieve novel protein drug delivery into proapoptosis lung cancer cells by precisely inhibiting survivin

Simple and Efficient Targeted Intracellular Protein Delivery with Self‐Assembled Nanovehicles for Effective Cancer Therapy